Immix Historical Balance Sheet
| IMMX Stock | USD 2.35 0.06 2.62% |
Trend analysis of Immix Biopharma balance sheet accounts such as Other Current Liabilities of 2.4 M or Total Current Liabilities of 2.4 M provides information on Immix Biopharma's total assets, liabilities, and equity, which is the actual value of Immix Biopharma to its prevalent stockholders. By breaking down trends over time using Immix Biopharma balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Immix Biopharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Immix Biopharma is a good buy for the upcoming year.
Immix |
About Immix Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Immix Biopharma at a specified time, usually calculated after every quarter, six months, or one year. Immix Biopharma Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Immix Biopharma and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Immix currently owns. An asset can also be divided into two categories, current and non-current.
Immix Biopharma Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Immix Biopharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Immix Biopharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Immix Biopharma balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Immix Biopharma are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from Immix Biopharma's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Immix Biopharma current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immix Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more information on how to buy Immix Stock please use our How to Invest in Immix Biopharma guide.At this time, Immix Biopharma's Other Current Liabilities is fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 15.9 M in 2024, whereas Total Assets are likely to drop slightly above 12 M in 2024.
| 2021 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 50K | 45K | 42.8K | Total Assets | 18.2M | 19.9M | 12.0M |
Immix Biopharma balance sheet Correlations
Click cells to compare fundamentals
Immix Biopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immix Stock Analysis
When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.